| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Interwest Management Partners IX, LLC last filed a Form 4 in June 2015, as 10% Owner at KALV. The filings on record cover 2 companies.
At the last filing, the largest reported position was 2,603,362 shares of GKOS.
Interwest Management Partners IX, LLC has 2 Form 4 filings on record from April 2015 to June 2015, across 2 companies: 10% Owner at Glaukos (GKOS), 2015; 10% Owner at KalVista Pharmaceuticals (KALV), 2015.
The 6 reported transactions were 5 conversions and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $4.0M and no sales.
The only open-market purchase was 810,000 shares of KALV at an average $5.00 on April 14, 2015, about $4.0M.
Shares as reported in the last Form 4 for each company; the most recent is from June 2015. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2015 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Buy | 810,000 | $5.00 | $4,050,000.00 | +21.3% |